immunotherapy
MYC Helps Cancer Hide
MYC Helps Cancer Hide
Anna Azvolinsky | Mar 10, 2016
The transcriptional regulator dampens the immune system’s ability to elicit an antitumor response, a study shows.
Single Antibody Protects Macaques from Ebola
Single Antibody Protects Macaques from Ebola
Amanda B. Keener | Feb 25, 2016
The “just right” binding properties of a monoclonal antibody from an Ebolavirus survivor help it neutralize the virus.
Week in Review: November 2–6
Week in Review: November 2–6
Jef Akst | Nov 6, 2015
How Ebola hides from immune cells; gut microbes’ role in immunotherapy response; new mechanisms of hearing loss; butterflies use milkweed toxins to ward off predators
Two-Faced Proteins May Tackle HIV Reservoirs
Two-Faced Proteins May Tackle HIV Reservoirs
Amanda B. Keener | Oct 21, 2015
Researchers design antibody-like proteins to awaken and destroy HIV holdouts.
Biotech Buys Autoimmune Firm for $7B
Biotech Buys Autoimmune Firm for $7B
Kerry Grens | Jul 16, 2015
Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.
Viral Immunotherapy for Melanoma
Viral Immunotherapy for Melanoma
Kerry Grens | May 28, 2015
Phase 3 data from a clinical trial show a positive response to a melanoma treatment based on a modified herpesvirus.
<em>The Scientist</em> on the Pulse, April 23
The Scientist on the Pulse, April 23
Kerry Grens | Apr 23, 2015
Hot topics in cancer research from the annual meeting of the American Association for Cancer Research
Opinion: Predicting the Efficacy of Cancer Immunotherapy
Opinion: Predicting the Efficacy of Cancer Immunotherapy
Jacob Richards | Apr 22, 2015
T-cell receptor repertoires could help researchers determine whether a certain treatment will work for a given cancer patient. 
HIV Antibody Therapy
HIV Antibody Therapy
Jef Akst | Apr 8, 2015
Delivering antibodies to HIV-infected people can lower levels of the virus, a study shows.
Another CAR-T IPO
Another CAR-T IPO
Jef Akst | Apr 6, 2015
Cellectis goes public for a whopping $228 million—nearly double the value the company filed for in February.